Microglial mitochondrial DNA release contributes to neuroinflammation after intracerebral hemorrhage through

Feng Gu1, Zongqi Wang1, Haojie Ding1

  • 1Department of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, Soochow University, Suzhou 215006, China; Institute of Stroke Research, Soochow University, Suzhou 215006, China.

Experimental Neurology
|September 15, 2024
PubMed

Insights

Mitochondrial DNA in microglia cytoplasm activates AIM2 inflammasome, causing brain injury after intracerebral hemorrhage (ICH). Blocking this interaction with P202 reduces inflammation and improves neurological function in mice.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Intracerebral hemorrhage (ICH) is a severe condition leading to significant disability and death.
  • Neuroinflammation is a critical factor in secondary brain injury following ICH.
  • The AIM2 inflammasome, a DNA-sensing complex, plays a role in neuroinflammation.

Purpose of the Study:

  • To investigate the role of mitochondrial DNA (mtDNA) in AIM2 inflammasome activation after ICH.
  • To explore the therapeutic potential of targeting the AIM2-mtDNA interaction for neurological recovery.

Main Methods:

  • An in vivo mouse model of ICH and an in vitro BV2 microglial cell model using oxyhemoglobin.
  • Overexpression of an AIM2 antagonist (P202) via lentiviral transfection.
  • Manipulation of cytosolic mtDNA levels using Mdivi-1 and mtDNA transfection.

Main Results:

  • Overexpression of P202 decreased AIM2 inflammasome proteins, reduced neuronal death, and improved neurological function.
  • Cytosolic mtDNA levels were found to regulate AIM2 inflammasome activation and inflammatory cytokine release.
  • Increased cytosolic mtDNA in microglia around the hematoma correlated with AIM2 activation and neuronal apoptosis.

Conclusions:

  • Elevated cytosolic mtDNA in microglia contributes to AIM2 inflammasome activation, leading to neuronal apoptosis and neurological deficits post-ICH.
  • The AIM2 antagonist P202 mitigates ICH-induced brain injury by inhibiting the AIM2-mtDNA interaction, thereby improving neurological outcomes.